Randomized phase II trial comparing IG-001 versus paclitaxel against first-line advanced ovarian cancer.

被引：0
|
作者：
Trieu, Vuong N. [1 ]
Choi, Monica [1 ]
Hwang, Larn [1 ]
D'Cruz, Osmond [1 ]
机构：
[1] Sorrento Therapeut, Irvine, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.5590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5590
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence
    J Sandercock
    MKB Parmar
    V Torri
    British Journal of Cancer, 1998, 78 : 1471 - 1478
  • [22] Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
    Meier, Werner
    du Bois, Andreas
    Rau, Joern
    Gropp-Meier, Martina
    Baumann, Klaus
    Huober, Jens
    Wollschlaeger, Kerstin
    Kreienberg, Rolf
    Canzler, Ulrich
    Schmalfeldt, Barbara
    Wimberger, Pauline
    Richter, Barbara
    Schroeder, Willibald
    Belau, Antje
    Staehle, Anne
    Burges, Alexander
    Sehouli, Jalid
    GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 236 - 240
  • [23] Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
    duBois, A
    Luck, HJ
    Bauknecht, T
    Mobus, V
    Bochtler, H
    Diergarten, K
    Meerpohl, HG
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 355 - 361
  • [24] First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: A phase I study
    Sehouli, J
    Stengel, D
    Elling, D
    Ortmann, O
    Blohmer, J
    Riess, H
    Lichtenegger, W
    GYNECOLOGIC ONCOLOGY, 2002, 85 (02) : 321 - 326
  • [25] Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma
    Vasey, PA
    Jayson, GC
    Gordon, A
    Gabra, H
    Coleman, R
    Atkinson, R
    Parkin, D
    Paul, J
    Hay, A
    Kaye, SB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (22): : 1682 - 1691
  • [26] Randomized phase II trial of weekly squalamine, carboplatin, and paclitaxel as first line therapy for advanced non-small cell lung cancer.
    Rose, V
    Schiller, J
    Wood, A
    Eskander, E
    Holroyd, K
    Desai, A
    Lee, JT
    Ahmed, M
    Kim, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 643S - 643S
  • [27] Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer:: A gynecologic cancer intergroup trial of the AGO-OVAR and GINECO
    Pfisterer, Jacobus
    Weber, Beatrice
    Reuss, Alexander
    Kimmig, Rainer
    du Bois, Andreas
    Wagner, Uwe
    Bourgeois, Hugues
    Meier, Werner
    Costa, Serban
    Blohmer, Jens-Uwe
    Lortholary, Alain
    Olbricht, Sigrid
    Staehle, Anne
    Jackisch, Christian
    Hardy-Bessard, Anne-Claire
    Moebus, Volker
    Quaas, Jens
    Richter, Barbara
    Schroeder, Willibald
    Geay, Jean-Francois
    Lueck, Hans-Joachim
    Kuhn, Walther
    Meden, Harald
    Nitz, Ulrike
    Pujade-Lauraine, Eric
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (15): : 1036 - 1045
  • [28] A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
    Ni, Lu
    Zhang, Weihan
    Chen, Ye
    Leng, Weibing
    Gou, Hongfeng
    Hu, Jiankun
    Qiu, Meng
    MEDICINE, 2021, 100 (17) : E25493
  • [29] Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial
    Robert, Nicholas J.
    Saleh, Mansoor N.
    Paul, Devchand
    Generali, Daniele
    Gressot, Laurent
    Copur, Mehmet S.
    Brufsky, Adam M.
    Minton, Susan E.
    Giguere, Jeffrey K.
    Smith, John W., II
    Richards, Paul D.
    Gernhardt, Diana
    Huang, Xin
    Liau, Katherine F.
    Kern, Kenneth A.
    Davis, John
    CLINICAL BREAST CANCER, 2011, 11 (02) : 82 - 92
  • [30] Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
    De Lena, M
    Lorusso, V
    Latorre, A
    Fanizza, G
    Gargano, G
    Caporusso, L
    Guida, M
    Catino, A
    Crucitta, E
    Sambiasi, D
    Mazzei, A
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) : 364 - 368
12345